NWO-VIDI grant awarded to Dr. Sylvestre Bonnet

17. 1. 2013 | Susan

Sylvestre Bonnet received a NWO-VIDI grant for his proposal “Light-activatable ruthenium-based anticancer prodrugs”. All anticancer drugs have severe side effects for patients due to their high toxicity. The awarded VIDI research project consists of making new metallodrugs that are poorly toxic in the dark, but become very toxic and selectively kill cancer cells upon visible light irradiation.